Date published: 2026-2-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

IFI-204 Activators

IFI-204 Activators are a group of chemical compounds that indirectly enhance the functional activity of IFI-204, a protein involved in immune response and antiviral mechanisms. Compounds such as Interferon-alpha and Interferon-beta work by activating the JAK-STAT signaling pathway, leading to the upregulation of immune response genes, including IFI-204. These interferons are critical in enhancing the expression of IFI-204, playing a pivotal role in antiviral responses. Other compounds like Resveratrol, Curcumin, and (-)-Epigallocatechin Gallate modulate various signaling pathways that can influence the activity of IFI-204. Resveratrol, through its action on sirtuin and AMPK pathways, and Curcumin, via its broad effects on cellular signaling, could potentially lead to enhanced regulation of IFI-204 in immune response mechanisms. (-)-Epigallocatechin Gallate, as a polyphenol, could influence cellular metabolism and immune responses, thereby potentially modulating IFI-204 activity.

Additionally, compounds targeting epigenetic regulators and signaling pathways, such as JQ1, PD 0325901, 5-Azacytidine, and Sodium Butyrate, could indirectly enhance IFI-204 activity. JQ1, by influencing chromatin remodeling, and 5-Azacytidine, through its action as a DNA methyltransferase inhibitor, might alter the expression patterns of genes including IFI-204. Sodium Butyrate, as a histone deacetylase inhibitor, could also affect the regulation of genes involved in the immune response. Furthermore, inhibitors like BAY 11-7082, LY 294002, and SB 203580, which target NF-κB, PI3K/AKT, and p38 MAPK pathways, respectively, might modulate signaling pathways that impact IFI-204 expression and function. These diverse activators highlight the intricate network of signaling pathways and epigenetic mechanisms that regulate the activity of IFI-204, emphasizing its importance in immune and stress response pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol could enhance IFI-204 activity by modulating sirtuin and AMPK pathways, which might influence cellular stress responses and potentially upregulate IFI-204 in certain contexts.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin may influence IFI-204 activity by affecting various cellular signaling pathways, potentially leading to enhanced regulation of IFI-204 in immune response mechanisms.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin gallate, a polyphenol, could potentially enhance IFI-204 activity by modulating signaling pathways involved in cellular metabolism and immune responses.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1, a BET bromodomain inhibitor, might enhance IFI-204 activity by influencing chromatin remodeling and gene expression patterns, potentially affecting the expression of IFI-204.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine, a DNA methyltransferase inhibitor, might enhance IFI-204 expression by altering epigenetic marks, leading to changes in the gene expression profile, including IFI-204.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium Butyrate, a histone deacetylase inhibitor, could potentially enhance IFI-204 activity by affecting gene expression patterns, including the regulation of genes involved in the immune response.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

BAY 11-7082, a NF-κB inhibitor, might influence IFI-204 activity by modulating NF-κB signaling, potentially impacting the expression of IFI-204 in immune and inflammatory responses.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002, a PI3K inhibitor, could indirectly enhance IFI-204 activity by affecting PI3K/AKT pathway signaling, potentially influencing the regulation of IFI-204.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB 203580, a p38 MAPK inhibitor, might shift signaling towards pathways involving IFI-204, potentially enhancing its activity in immune and stress response pathways.